Thrombolysis: From the experimental findings to the clinical practice

被引:12
作者
del Zoppo, GJ
机构
[1] Scripps Res Inst, Dept Mol & Expt Med, La Jolla, CA 92037 USA
[2] Scripps Clin, Dept Med, Div Hematol Med Oncol, La Jolla, CA USA
关键词
thrombolysis; plasminogen activators; clinical trials; animal models; hemorrhage;
D O I
10.1159/000074807
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Antithrombotic strategies have provided the most benefit to patients with ischemic stroke. Of these, the acute use of recombinant tissue plasminogen activator (rt-PA) has been shown to significantly increase the number of patients who suffer little or no residual disability. Experimental work indicated that early reperfusion of occluded brainsupplying arteries reduces the size of injury and improves outcome in several species. However, there has been little progress to increase the proportion of patients who are benefitted by acute intervention with PAs since the initial report. Clinical trial experience highlights limitations in a number of aspects of design and outcome which suggest refinements for future trials. Experimental work suggests that improved outcome is also possible with acute intervention using other antithrombotic agents. There is considerable opportunity to explore safe strategies which could further benefit stroke outcome. Copyright (C) 2004 S. Karger AG, Basel.
引用
收藏
页码:144 / 152
页数:9
相关论文
共 77 条
[31]   Intra-arterial prourokinase for acute ischemic stroke - The PROACT II study: A randomized controlled trial [J].
Furlan, A ;
Higashida, R ;
Wechsler, L ;
Gent, M ;
Rowley, H ;
Kase, C ;
Pessin, M ;
Ahuja, A ;
Callahan, F ;
Clark, WM ;
Silver, F ;
Rivera, F .
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1999, 282 (21) :2003-2011
[32]   CHARACTERIZATION OF A SOLUBLE D-DIMER-E COMPLEX IN CROSSLINKED FIBRIN DIGESTS [J].
GAFFNEY, PJ ;
LANE, DA ;
KAKKAR, VV ;
BRASHER, M .
THROMBOSIS RESEARCH, 1975, 7 (01) :89-99
[33]   Weight-adjusted dosing of TNK-tissue plasminogen activator and its relation to angiographic outcomes in the thrombolysis in myocardial infarction 10B trial [J].
Gibson, CM ;
Cannon, CP ;
Murphy, SA ;
Adgey, AAJ ;
Schweiger, MJ ;
Sequeira, RF ;
Grollier, G ;
Fox, NL ;
Berioli, S ;
Weaver, WD ;
Van de Werf, F ;
Braunwald, E .
AMERICAN JOURNAL OF CARDIOLOGY, 1999, 84 (09) :976-980
[34]   RODENT MODELS OF CEREBRAL-ISCHEMIA [J].
GINSBERG, MD ;
BUSTO, R .
STROKE, 1989, 20 (12) :1627-1642
[35]   Randomised double-blind placebo-controlled trial of thrombolytic therapy with intravenous alteplase in acute ischaemic stroke (ECASS II) [J].
Hacke, W ;
Kaste, M ;
Fieschi, C ;
von Kummer, R ;
Davalos, A ;
Meier, D ;
Larrue, V ;
Bluhmki, E ;
Davis, S ;
Donnan, G ;
Schneider, D ;
Diez-Tejedor, E ;
Trouillas, P .
LANCET, 1998, 352 (9136) :1245-1251
[36]   INTRA-ARTERIAL THROMBOLYTIC THERAPY IMPROVES OUTCOME IN PATIENTS WITH ACUTE VERTEBROBASILAR OCCLUSIVE DISEASE [J].
HACKE, W ;
ZEUMER, H ;
FERBERT, A ;
BRUCKMANN, H ;
DELZOPPO, GJ .
STROKE, 1988, 19 (10) :1216-1222
[37]  
HACKE W, 1995, JAMA-J AM MED ASSOC, V274, P1017, DOI 10.1001/jama.274.13.1017
[38]   Dichotomized efficacy end points and global end-point analysis applied to the ECASS intention-to-treat data set - Post hoc analysis of ECASS I [J].
Hacke, W ;
Bluhmki, E ;
Steiner, T ;
Tatlisumak, T ;
Mahagne, MH ;
Sacchetti, ML ;
Meier, D .
STROKE, 1998, 29 (10) :2073-2075
[39]   Hemorrhagic transformation and microvascular integrity during focal cerebral ischemia/reperfusion [J].
Hamann, GF ;
Okada, Y ;
delZoppo, GJ .
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1996, 16 (06) :1373-1378
[40]   MICROVASCULAR BASAL LAMINA ANTIGENS DISAPPEAR DURING CEREBRAL-ISCHEMIA AND REPERFUSION [J].
HAMANN, GF ;
OKADA, Y ;
FITRIDGE, R ;
DELZOPPO, GJ .
STROKE, 1995, 26 (11) :2120-2126